Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%

Q: How long will it take to read this news story?

The story "Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%" has 394 words across 17 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10%" was covered 4 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 312 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #21751822</li><li>URL: https://beamstart.com/news/torrent-pharma-q1fy25-results-net-17217410915697</li></ul>

Business Standard Logo Business Standard 4h ago

Torrent Pharma Q1FY25 results: Net profit up 21%, revenue rises 10% - Business Standard

Quick Summary:

The company stated that their primary sales in the Brazil market were impacted by severe floods in the Rio Grande do Sul province in April and May 2024.

HUL Q1 results: Net profit rises 2.2% to Rs 2,610 crore, revenue up 1.

The company also informed that it entered into a non-exclusive licensing agreement with Takeda Pharmaceuticals to commercialise its novel potassium-competitive acid blocker (P-CAB) Vonoprazan in India during the June quarter of FY25.